
Medyvine Pharmaceuticals Private Limited
About Medyvine Pharmaceuticals Private Limited
Data last updated:
Medyvine Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC384245.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Bikas Kumar (Managing Director) and Pallavi Kumari.
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S/O – Shridhar Jha Plot – 26 Block – A Shrichand Park Uttam Nagar Matiyala Road, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.19 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹3,004 (net margin 0.1%) and EBITDA of ₹49,568 (EBITDA margin 2%).
Company details
Contact details
Medyvine Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressS/O – Shridhar Jha Plot – 26 Block – A Shrichand Park Uttam Nagar Matiyala Road, Delhi, India – 110059
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medyvine Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medyvine Pharmaceuticals Private Limited, buy the company report.
Financials of Medyvine Pharmaceuticals Private Limited
FY 2024 filings availableMedyvine Pharmaceuticals Private Limited reported revenue of ₹24.19 Lakh (down 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year. EBITDA rose 51% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹49,568 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3,004 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2% | ||
| Net Profit Margin | 0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medyvine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medyvine Pharmaceuticals Private Limited
Medyvine Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bikas Kumar | Managing Director | 27 Jul 2021 | 5 Years 3 Months | Current |
| Pallavi Kumari | Director | 27 Jul 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Medyvine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medyvine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medyvine Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medyvine Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Bikas Kumar was appointed as Managing Director on 27 Jul 2021.
Frequently asked questions
Medyvine Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 July 2021 (5+ years old) and is registered under CIN U24290DL2021PTC384245.
Medyvine Pharmaceuticals has 2 current directors:
- Bikas Kumar - Managing Director
- Pallavi Kumari - Director
The latest financial statements of Medyvine Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 09 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Medyvine Pharmaceuticals is U24290DL2021PTC384245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medyvine Pharmaceuticals was incorporated on 27 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Bikas Kumar was appointed as Managing Director on 27 Jul 2021. Pallavi Kumari was appointed as Director on 27 Jul 2021.
The registered office of Medyvine Pharmaceuticals is at SO – Shridhar Jha Plot – 26 Block – A Shrichand Park Uttam Nagar Matiyala Road, Delhi, India – 110059.
Medyvine Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Medyvine Pharmaceuticals can be reached at its registered office: SO – Shridhar Jha Plot – 26 Block – A Shrichand Park Uttam Nagar Matiyala Road, Delhi, India – 110059.
Medyvine Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

